North America

Natus Integrates Moberg CNS Monitor with NeuroWorks for Advanced EEG Capabilities

The integration enhances multimodal brain monitoring by streamlining EEG data access, visualization, and clinical decision-making in critical care environments....

Hesperos Unveils First Digital Twin of Human Disease with Organ-on-a-Chip Breakthrough

Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....

SkylineDx's Merlin Melanoma Assay Validated to Reduce Sentinel Lymph Node Biopsies by Over 40%

Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...

Texas Cardiac Arrhythmia Institute Becomes First in U.S. to Use FDA-Approved Wireless System for Arrhythmia Treatment

St. David's Medical Center pioneers clinical use of innovative wireless EP solution, marking a new chapter in minimally invasive cardiac care....

Milestone Scientific Begins CompuFlo® Epidural System Sales at The Painless Center

Innovative pressure-sensing technology now in use at leading New Jersey pain management clinic, enhancing safety and precision in epidural procedures...

Globus Medical Launches DuraPro™ with Navigation

Next-Generation Oscillating System Enhances Precision and Protects Delicate Tissue in Spine and Cranial Procedures...

HemoSonics Honored with 2025 Supplier Horizon Award by Premier, Inc.

Award Recognizes HemoSonics’ Innovative Contributions and Exceptional Support in Advancing Diagnostic Hemostasis Solutions Across Premier’s Member Network...

UroMems Secures FDA and ANSM Clearance to Begin Pivotal Study of UroActive® Smart Implant for Male SUI

Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men...

Olympus Launches EU-ME3 Ultrasound Processor in U.S. for Advanced GI and Pulmonary Disease Detection

Next-Generation Platform Enhances Endoscopic Ultrasound Imaging to Support More Accurate and Efficient Diagnoses...

Oncomine Dx Express Test Gains FDA Approval, Expanding Thermo Fisher’s Precision Oncology Portfolio

The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....